196 related articles for article (PubMed ID: 36372899)
1. Inequalities in the impact of COVID-19-associated disruptions on tuberculosis diagnosis by age and sex in 45 high TB burden countries.
McQuaid CF; Henrion MYR; Burke RM; MacPherson P; Nzawa-Soko R; Horton KC
BMC Med; 2022 Nov; 20(1):432. PubMed ID: 36372899
[TBL] [Abstract][Full Text] [Related]
2. Retrospective Cohort Study of Effects of the COVID-19 Pandemic on Tuberculosis Notifications, Vietnam, 2020.
Hasan T; Nguyen VN; Nguyen HB; Nguyen TA; Le HTT; Pham CD; Hoang N; Nguyen PTM; Beardsley J; Marks GB; Fox GJ
Emerg Infect Dis; 2022 Mar; 28(3):684-692. PubMed ID: 35202526
[TBL] [Abstract][Full Text] [Related]
3. Global impact of COVID-19 on childhood tuberculosis: an analysis of notification data.
Ranasinghe L; Achar J; Gröschel MI; Whittaker E; Dodd PJ; Seddon JA
Lancet Glob Health; 2022 Dec; 10(12):e1774-e1781. PubMed ID: 36400083
[TBL] [Abstract][Full Text] [Related]
4. Sex Differences in Tuberculosis Burden and Notifications in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.
Horton KC; MacPherson P; Houben RM; White RG; Corbett EL
PLoS Med; 2016 Sep; 13(9):e1002119. PubMed ID: 27598345
[TBL] [Abstract][Full Text] [Related]
5. Trends in burden of multidrug-resistant tuberculosis in countries, regions, and worldwide from 1990 to 2017: results from the Global Burden of Disease study.
Ou ZJ; Yu DF; Liang YH; He WQ; Li YZ; Meng YX; Xiong HS; Zhang MY; He H; Gao YH; Wu F; Chen Q
Infect Dis Poverty; 2021 Mar; 10(1):24. PubMed ID: 33676581
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
Harausz EP; Garcia-Prats AJ; Law S; Schaaf HS; Kredo T; Seddon JA; Menzies D; Turkova A; Achar J; Amanullah F; Barry P; Becerra M; Chan ED; Chan PC; Ioana Chiotan D; Crossa A; Drobac PC; Fairlie L; Falzon D; Flood J; Gegia M; Hicks RM; Isaakidis P; Kadri SM; Kampmann B; Madhi SA; Marais E; Mariandyshev A; Méndez-Echevarría A; Moore BK; Nargiza P; Ozere I; Padayatchi N; Ur-Rehman S; Rybak N; Santiago-Garcia B; Shah NS; Sharma S; Shim TS; Skrahina A; Soriano-Arandes A; van den Boom M; van der Werf MJ; van der Werf TS; Williams B; Yablokova E; Yim JJ; Furin J; Hesseling AC;
PLoS Med; 2018 Jul; 15(7):e1002591. PubMed ID: 29995958
[TBL] [Abstract][Full Text] [Related]
8. Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network study.
Nalunjogi J; Mucching-Toscano S; Sibomana JP; Centis R; D'Ambrosio L; Alffenaar JW; Denholm J; Blanc FX; Borisov S; Danila E; Duarte R; García-García JM; Goletti D; Ong CWM; Rendon A; Thomas TA; Tiberi S; van den Boom M; Sotgiu G; Migliori GB;
Int J Infect Dis; 2023 May; 130 Suppl 1():S25-S29. PubMed ID: 36893943
[TBL] [Abstract][Full Text] [Related]
9. Women and tuberculosis.
Connolly M; Nunn P
World Health Stat Q; 1996; 49(2):115-9. PubMed ID: 9050189
[TBL] [Abstract][Full Text] [Related]
10. Sociodemographic Characteristics, Comorbidities, and Mortality Among Persons Diagnosed With Tuberculosis and COVID-19 in Close Succession in California, 2020.
Nabity SA; Han E; Lowenthal P; Henry H; Okoye N; Chakrabarty M; Chitnis AS; Kadakia A; Villarino E; Low J; Higashi J; Barry PM; Jain S; Flood J
JAMA Netw Open; 2021 Dec; 4(12):e2136853. PubMed ID: 34860244
[TBL] [Abstract][Full Text] [Related]
11. The impact of the COVID-19 pandemic on the global tuberculosis epidemic.
Falzon D; Zignol M; Bastard M; Floyd K; Kasaeva T
Front Immunol; 2023; 14():1234785. PubMed ID: 37795102
[TBL] [Abstract][Full Text] [Related]
12. The risk of multidrug- or rifampicin-resistance in males
McQuaid CF; Horton KC; Dean AS; Knight GM; White RG
Eur Respir J; 2020 Sep; 56(3):. PubMed ID: 32430421
[TBL] [Abstract][Full Text] [Related]
13. Early COVID-19 pandemic's toll on tuberculosis services, WHO European Region, January to June 2020.
Dara M; Kuchukhidze G; Yedilbayev A; Perehinets I; Schmidt T; Van Grinsven WL; Boeree MJ
Euro Surveill; 2021 Jun; 26(24):. PubMed ID: 34142649
[TBL] [Abstract][Full Text] [Related]
14. HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis.
Sultana ZZ; Hoque FU; Beyene J; Akhlak-Ul-Islam M; Khan MHR; Ahmed S; Hawlader DH; Hossain A
BMC Infect Dis; 2021 Jan; 21(1):51. PubMed ID: 33430786
[TBL] [Abstract][Full Text] [Related]
15. Situational analysis of 10 countries with a high burden of drug-resistant tuberculosis 2 years post-UNHLM declaration: progress and setbacks in a changing landscape.
Monedero-Recuero I; Gegia M; Wares DF; Chadha SS; Mirzayev F
Int J Infect Dis; 2021 Jul; 108():557-567. PubMed ID: 34139370
[TBL] [Abstract][Full Text] [Related]
16. Trends of type 2 diabetes with pulmonary tuberculosis patients,2013-2022, and changes after the coronavirus disease 2019 (COVID-19) pandemic.
Wang Z; Zhao S; Zhang A; Quan B; Duan C; Liang M; Yang J
Tuberculosis (Edinb); 2024 May; 146():102499. PubMed ID: 38442538
[TBL] [Abstract][Full Text] [Related]
17. Tuberculosis in the Russian Federation: Prognosis and Epidemiological Models in a Situation After the COVID-19 Pandemic.
Starshinova A; Belyaeva E; Doktorova N; Korotkevich I; Kudlay D
J Epidemiol Glob Health; 2023 Mar; 13(1):11-22. PubMed ID: 36740623
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Disability-Adjusted Life Years (DALYs) and Economic Burden on People With Drug-Susceptible Tuberculosis and Multidrug-Resistant Tuberculosis in Korea.
Lee S; Kim MJ; Lee SH; Kim HY; Kim HS; Oh IH
Front Public Health; 2022; 10():848370. PubMed ID: 35480575
[TBL] [Abstract][Full Text] [Related]
19. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
van Maaren PJ
Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
